APHEA.BIO
Aphea.Bio will develop next generation โbiopesticidesโ based on natural microorganisms. These products will provide an alternative for chemical pesticides, which are currently under serious pressure. In addition, the company will develop novel โbiostimulantsโ, i.e. microorganisms that stimulate crop growth, for example through promoting the uptake of nutrients from the soil.
APHEA.BIO
Industry:
Agriculture Biotechnology Chemical
Founded:
2017-06-26
Address:
Zwijnaarde, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.aphea.bio
Total Employee:
11+
Status:
Active
Contact:
+32470821617
Email Addresses:
[email protected]
Total Funding:
101 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Tag Manager SSL By Default HSTS IPv6 Cloudflare Hosting Nginx
Similar Organizations
Agriprotein
Agriprotein specializes in nutrient recycling to create sustainable sources of protein for the mono-gastric animal feed industry.
Atlas Agro
Feeding the world without emissions
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Simris
Simris produces unique ingredients from farmed microalgae instead of fish and other marine animals.
Zhiyi Pharmaceutics
Zhiyi Pharmaceutics focuses on the research and development of second-generation probiotics and Live Biotherapeutics.
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series C - Aphea.Bio
Agri Investment Fund
Agri Investment Fund investment in Series C - Aphea.Bio
European Circular Bioeconomy Fund
European Circular Bioeconomy Fund investment in Series C - Aphea.Bio
Astanor Ventures
Astanor Ventures investment in Series C - Aphea.Bio
SFPIM
SFPIM investment in Series C - Aphea.Bio
Innovation Industries
Innovation Industries investment in Series C - Aphea.Bio
BNP Paribas Fortis
BNP Paribas Fortis investment in Series C - Aphea.Bio
Korys
Korys investment in Series C - Aphea.Bio
V-Bio Ventures
V-Bio Ventures investment in Series B - Aphea.Bio
Astanor Ventures
Astanor Ventures investment in Series B - Aphea.Bio
Official Site Inspections
http://www.aphea.bio Semrush global rank: 11.03 M Semrush visits lastest month: 173
- Host name: 104.21.11.32
- IP address: 104.21.11.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aphea.Bio"
Home | Aphea.Bio
Aphea.Bio develops biocontrol and biostimulant products by harnessing the diversity of microorganisms through our APEXbioโข R&D platform.See details»
About Us | Aphea.Bio
Aphea.Bio is a research-driven company dedicated to offer alternative, more sustainable solutions for achieving food security without environmental damage.See details»
Aphea.Bio - Crunchbase Company Profile & Funding
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides. Aphea.Bio may be growing as evidenced by a recent funding โฆSee details»
Aphea.Bio joins the International Phytobiomes Alliance
Feb 25, 2020 The Belgium-based biotechnology company Aphea.Bio was founded in 2017 as a spin-off of VIB, a life sciences research institute in Flanders, Belgium, and its partner universities UGent and KU Leuven.See details»
Aphea.Bio | Biological Products Industry Alliance - BPIA
Our mission is to ensure food security and create a safe, healthy food chain with novel, science-based solutions for sustainable, reliable, and profitable agriculture.See details»
Aphea Bio - Certified B Corporation - B Lab Global
Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. Using naturally occurring micro-organisms, the develop novel science-based solutions for the โฆSee details»
Aphea.Bio - International Phytobiomes Alliance
Aphea.Bio was founded in 2017 as a spin-off of the VIB and its partner universities UGent and KU Leuven and has raised about 10 million US$ in funding. The company can count on a solid โฆSee details»
Aphea.Bio becomes a Certified B Corporation, demonstrating high ...
Jun 23, 2023 Aphea.Bio was founded by Isabel Vercauteren (now CEO of Aphea.Bio) and Steven Vandenabeele (now CTO of Aphea.Bio) on 5 December 2016 as a spin-off of the VIB โฆSee details»
Bill and Melinda Gates Foundation backs Belgian โฆ
Jul 14, 2023 Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. The company aims to provide novel, science-based solutions to build the agriculture of the future: sustainable, reliable, and profitable.See details»
Aphea.Bio, a Portfolio Company of ECBF, raises a โฆ
Aphea.Bio is a fully integrated microbial product development company dedicated to food security and ensuring a safe and healthy food chain and is providing novel, science-based solutions to build the agriculture of the future: โฆSee details»
Aphea.Bio Company Profile 2024: Valuation, Funding
Aphea.Bio General Information Description. Producer of agricultural products intended to increase crop yields and crop health. The company's products help to reduce fertilizer application and control fungal diseases, pests, and weeds โฆSee details»
The story of Aphea.Bio: from frontier research to leading R&D
Aphea.Bioโscore business is to develop biocontrol and biostimulant products for cereal crops A big opportunity for farmers and investors Cereals Wheat (220Mi ha globally, ~30Mi ha in Europe) โฆSee details»
Aphea.Bio secures โฌ 70 million Series C Funding, accelerating
Nov 7, 2023 Aphea.Bio is a fully integrated microbial product development company dedicated to food security and ensuring a safe and healthy food chain and is providing novel, science โฆSee details»
ApheaBio | Driving the revolution in biologicals
Home; Company; Challenge; Approach; Technology; Sustainability; Manifesto; Board; News; Careers; Our manifesto. Change is not a destination. It's a journey of courage.See details»
Aphea.Bio Raises $10m in Series A and Grant Funding for
Jun 26, 2017 Belgian startup Aphea.Bio has launched into the biopesticides and biostimulants sector with โฌ9 million ($10.07m) in funding from a Series A funding round and a local R&D โฆSee details»
Aphea.Bio - Funding, Financials, Valuation & Investors - Crunchbase
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much โฆSee details»
Aphea.Bio secures โฌ 70 million Series C Funding
Aphea.Bio, a Belgium-based agricultural technology company, announced today the successful closing of its Series C Funding round, securing โฌ 70 million.See details»
Sustainability | Aphea.Bio
Aphea.Bio's B Corp certification is a testament to our commitment to balancing purpose and profit. "We are a proud member of the B Corp community. Our score of 94.5, well above 80 required โฆSee details»
Aphea.Bio will use Microorganisms to Replace Pesticides and โฆ
Jun 26, 2017 Aphea.Bio has raised โฌ7.7M in a Series A round led by the Belgian life sciences investor V-Bio Ventures in addition to a ... The World Health Organization (WHO) reports that โฆSee details»
Technology | Aphea.Bio
Our mission is to provide farmers with innovative and sustainable solutions to reduce fertilizer and pesticide use. Unravelling complex interactions and identifying beneficial microbial strains โฆSee details»